Abstract:Aims: Hydrogen sulfide (H2S) plays an essential role in bone formation, in part, by inhibiting osteoclast differentiation, maintaining mesenchymal stem cell osteogenesis ability, or reducing osteoblast injury. We aimed to investigate the role of H2S in osteoblast function and its possible molecular target. Results: In this study, we found that cystathionine c-lyase (CSE) majorly contributed to endogenous H2S production in the primary osteoblast. Overexpressed CSE increased osteoblast differentiation and matura… Show more
“…The H 2 S donor GYY4137 induced the same sulfhydrationdependent induction, whereas mutation of these Cys residues on RUNX2 or treatment with the CSE inhibitor dlpropargylglycine prevented RUNX2 sulfhydration, nuclear localization, and transactivation. Delivery of CSE using an adenoviral vector facilitated healing of fractured femurs in treated rats (315). The contrast between this study and those already mentioned, suggesting inhibition of osteopontin expression by H 2 S, may reflect a biphasic dose response, wherein physiological H 2 S induces osteopontin but supraphysiological concentrations are inhibitory.…”
Section: A Osteopontincontrasting
confidence: 87%
“…Treatment with 100 lM NaHS significantly decreased proliferation of VSMCs via an ERK1/ERK2-dependent pathway and partially inhibited the induction of osteopontin by homocysteine. In contrast, endogenous H 2 S produced by CSE induces differentiation and maturation of primary osteoblasts, resulting in induction of osteopontin and BMP2 expression (315). This is mediated by sulfhydration of the transcription factor RUNX2 at Cys 123 and Cys 132 and results in elevated BMP2, osteopontin, and osteocalcin expression (Fig.…”
Significance: In contrast to structural elements of the extracellular matrix, matricellular proteins appear transiently during development and injury responses, but their sustained expression can contribute to chronic disease. Through interactions with other matrix components and specific cell surface receptors, matricellular proteins regulate multiple signaling pathways, including those mediated by reactive oxygen and nitrogen species and H 2 S. Dysregulation of matricellular proteins contributes to the pathogenesis of vascular diseases and cancer. Defining the molecular mechanisms and receptors involved is revealing new therapeutic opportunities. Recent Advances: Thrombospondin-1 (TSP1) regulates NO, H 2 S, and superoxide production and signaling in several cell types. The TSP1 receptor CD47 plays a central role in inhibition of NO signaling, but other TSP1 receptors also modulate redox signaling. The matricellular protein CCN1 engages some of the same receptors to regulate redox signaling, and ADAMTS1 regulates NO signaling in Marfan syndrome. In addition to mediating matricellular protein signaling, redox signaling is emerging as an important pathway that controls the expression of several matricellular proteins. Critical Issues: Redox signaling remains unexplored for many matricellular proteins. Their interactions with multiple cellular receptors remains an obstacle to defining signaling mechanisms, but improved transgenic models could overcome this barrier. Future Directions: Therapeutics targeting the TSP1 receptor CD47 may have beneficial effects for treating cardiovascular disease and cancer and have recently entered clinical trials. Biomarkers are needed to assess their effects on redox signaling in patients and to evaluate how these contribute to their therapeutic efficacy and potential side effects. Antioxid. Redox Signal. 27, 874-911.
“…The H 2 S donor GYY4137 induced the same sulfhydrationdependent induction, whereas mutation of these Cys residues on RUNX2 or treatment with the CSE inhibitor dlpropargylglycine prevented RUNX2 sulfhydration, nuclear localization, and transactivation. Delivery of CSE using an adenoviral vector facilitated healing of fractured femurs in treated rats (315). The contrast between this study and those already mentioned, suggesting inhibition of osteopontin expression by H 2 S, may reflect a biphasic dose response, wherein physiological H 2 S induces osteopontin but supraphysiological concentrations are inhibitory.…”
Section: A Osteopontincontrasting
confidence: 87%
“…Treatment with 100 lM NaHS significantly decreased proliferation of VSMCs via an ERK1/ERK2-dependent pathway and partially inhibited the induction of osteopontin by homocysteine. In contrast, endogenous H 2 S produced by CSE induces differentiation and maturation of primary osteoblasts, resulting in induction of osteopontin and BMP2 expression (315). This is mediated by sulfhydration of the transcription factor RUNX2 at Cys 123 and Cys 132 and results in elevated BMP2, osteopontin, and osteocalcin expression (Fig.…”
Significance: In contrast to structural elements of the extracellular matrix, matricellular proteins appear transiently during development and injury responses, but their sustained expression can contribute to chronic disease. Through interactions with other matrix components and specific cell surface receptors, matricellular proteins regulate multiple signaling pathways, including those mediated by reactive oxygen and nitrogen species and H 2 S. Dysregulation of matricellular proteins contributes to the pathogenesis of vascular diseases and cancer. Defining the molecular mechanisms and receptors involved is revealing new therapeutic opportunities. Recent Advances: Thrombospondin-1 (TSP1) regulates NO, H 2 S, and superoxide production and signaling in several cell types. The TSP1 receptor CD47 plays a central role in inhibition of NO signaling, but other TSP1 receptors also modulate redox signaling. The matricellular protein CCN1 engages some of the same receptors to regulate redox signaling, and ADAMTS1 regulates NO signaling in Marfan syndrome. In addition to mediating matricellular protein signaling, redox signaling is emerging as an important pathway that controls the expression of several matricellular proteins. Critical Issues: Redox signaling remains unexplored for many matricellular proteins. Their interactions with multiple cellular receptors remains an obstacle to defining signaling mechanisms, but improved transgenic models could overcome this barrier. Future Directions: Therapeutics targeting the TSP1 receptor CD47 may have beneficial effects for treating cardiovascular disease and cancer and have recently entered clinical trials. Biomarkers are needed to assess their effects on redox signaling in patients and to evaluate how these contribute to their therapeutic efficacy and potential side effects. Antioxid. Redox Signal. 27, 874-911.
“…Haematoxylin and eosin (upper panels), von Kossa (middle panels), CSE (second middle panels), and α smooth muscle actin (α-SMA; lower panels) staining was performed on aortic valves of mice fed a normal diet (first column; N = 5), on a high-fat diet (second column, N = 9); and on a high-fat diet treated with AP72 (third column; N = 5). Comparison (>) designates the calcified regions, and arrow indicates CSE positive cells CSE-produced endogenous sulfide enhanced its transactivation (Zheng et al, 2017). This effect is in contrast to our observations that endogenously produced or exogenously administered sulfide inhibited nuclear translocation of RUNX2, suggesting that the anti-calcification effects of H 2 S are more likely due to the inhibition of phosphate uptake, and the inhibition of RUNX2 translocation in our model is likely to be a secondary effect of this, as we proposed above.…”
Background and Purpose
Calcification of heart valves is a frequent pathological finding in chronic kidney disease and in elderly patients. Hydrogen sulfide (H2S) may exert anti‐calcific actions. Here we investigated H2S as an inhibitor of valvular calcification and to identify its targets in the pathogenesis.
Experimental Approach
Effects of H2S on osteoblastic transdifferentiation of valvular interstitial cells (VIC) isolated from samples of human aortic valves were studied using immunohistochemistry and western blots. We also assessed H2S on valvular calcification in apolipoprotein E‐deficient (ApoE−/−) mice.
Key Results
In human VIC, H2S from donor compounds (NaSH, Na2S, GYY4137, AP67, and AP72) inhibited mineralization/osteoblastic transdifferentiation, dose‐dependently in response to phosphate. Accumulation of calcium in the extracellular matrix and expression of osteocalcin and alkaline phosphatase was also inhibited. RUNX2 was not translocated to the nucleus and phosphate uptake was decreased. Pyrophosphate generation was increased via up‐regulating ENPP2 and ANK1. Lowering endogenous production of H2S by concomitant silencing of cystathionine γ‐lyase (CSE) and cystathionine β‐synthase (CBS) favoured VIC calcification. analysis of human specimens revealed higher Expression of CSE in aorta stenosis valves with calcification (AS) was higher than in valves of aortic insufficiency (AI). In contrast, tissue H2S generation was lower in AS valves compared to AI valves. Valvular calcification in ApoE−/− mice on a high‐fat diet was inhibited by H2S.
Conclusions and Implications
The endogenous CSE‐CBS/H2S system exerts anti‐calcification effects in heart valves providing a novel therapeutic approach to prevent hardening of valves.
Linked Articles
This article is part of a themed section on Hydrogen Sulfide in Biology & Medicine. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v177.4/issuetoc
“…Nitrosylation of GAPDH inhibits, but sulfhydration enhances, its activity (Mustafa et al, ). Knockout of CSE (Mustafa et al, ), or inhibition of CSE activity (Zheng et al, ) lowered protein sulfhydration, which suggests that CSE might be a key enzyme for sulfhydration. In our experimental conditions, H 2 S donor treatment increased CSE protein expression and its sulfhydration but decreased its nitrosylation.…”
Background and Purpose
Hydrogen sulfide donors can block the cardiovascular injury of hyperhomocysteinemia. H
2
S also lowers serum homocysteine in rats with mild hyperhomocysteinemia, but the pharmacological mechanism is unknown. The present study investigated the mechanism(s) involved.
Experimental Approach
ApoE‐knockout mice were fed a Paigen diet and L‐methionine in drinking water for 16 weeks to create a mouse model of atherosclerosis with hyperhomocysteinemia. H
2
S donors (NaHS and GYY4137) were administered by intraperitoneal injection. We also assayed the H
2
S produced (by methylene blue assay and mito‐HS [H
2
S fluorescence probe]), cystathionine γ lyase (CSE) mRNA and protein expression, and CSE sulfhydration and nitrosylation and its activity.
Key Results
H
2
S donor treatment significantly lowered atherosclerotic plaque area, macrophage infiltration, and serum homocysteine level in the mouse model of atherosclerosis with co‐existing hyperhomocysteinemia. mRNA and protein levels of CSE, a key enzyme catalyzing homocysteine trans‐sulfuration, were down‐regulated with hyperhomocysteinemia, and CSE catalytic activity was inhibited. All these effects were reversed with H
2
S donor treatment. Hyperhomocysteinemia induced CSE nitrosylation, whereas H
2
S sulfhydrated CSE at the same cysteine residues. Nitrosylated CSE decreased and sulfhydrated CSE increased its catalytic and binding activities towards L‐homocysteine. Mutation of C252, C255, C307, and C310 residues in CSE abolished CSE nitrosylation or sulfhydration and prevented its binding to L‐homocysteine.
Conclusions and Implications
Sulfhydration or nitrosylation of CSE represents a yin/yang regulation of catalysis or binding to L‐homocysteine. H
2
S donor treatment enhanced CSE sulfhydration, thus lowering serum L‐homocysteine, which contributed in part to the anti‐atherosclerosis effects in ApoE‐knockout mice with hyperhomocysteinemia.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.